Concepedia

Publication | Open Access

Selective activation of angiotensin<scp>AT</scp><sub>2</sub>receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis

85

Citations

48

References

2014

Year

Abstract

Taken together, our results suggest that the AT2 receptor agonist, C21, may hold promise for patients with PH.

References

YearCitations

Page 1